Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with episodic migraine, chronic migraine, or chronic migraine with medication overuse headache, based on recognised international diagnostic guidelines
- People between 18 and 65 years of age
- People who had at least 2 migraine days in the month before joining the trial
- People who have had migraines for at least 12 months before joining the trial
- People who have signed a written consent form agreeing to take part
Who may not be able to join:
- People who have, or have previously been diagnosed with, a headache disorder caused by another underlying condition (such as injury or illness), according to recognised international diagnostic guidelines
- People who have a history of other neurological conditions or major mental health disorders
- People who have had migraines for less than 12 months before the trial start date
- People whose headaches are linked to overuse of opioid pain medications, as defined by recognised international diagnostic guidelines
- People who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +393926337082
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Frequency of each symptom as the first premonitory symptom
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.